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of 5-methyl tetrahydrofolate, which is the methyl donor in the reaction catalyzed by methionine synthase in presence of vitamin B12 as essential cofactor. 1, 2 The primary function of folate is carrying one-carbon unit for purine and thymidine synthesis and the conversion of Hcy to methionine. As there is a close relation between folate and Hcy, low folate status is reflected by elevated plasma total concentrations. 3 Dihydrofolate reductase (DHFR) is a necessary enzyme for the reduction of ingested folates before being used in the body metabolism. DHFR has a direct and important role in DNA synthesis. 4 Another key enzyme in the folate/Hcy metabolic pathway is thymidylate synthase (TYMS). It converts deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), providing the only intracellular de novo source of dTMP. TYMS encodes an enzyme that uses 5,10-MTHFR as a cofactor to maintain the dTMP pool critical for DNA replication and DNA repair. Trinh et al 5 and Kealey et al 6 suggest that TYMS and MTHFR compete for the available supply of 5,10-methyleneTHF. In the remethylation pathway, individuals who are homozygous for the "thermolabile" variant of the I n recent years, considerable interest has developed concerning the role of dietary folate and single nucleotide polymorphisms (SNPs) of genes that code for folate-dependent enzymes in disease processes. Mainly, they affect homocysteine (Hcy), a sulfur-containing amino acid synthesized from methionine that plays a key role between the folate and activated methyl cycles. There are 2 main metabolic pathways of Hcy synthesis: remethylation to methionine, which requires folate and vitamin B12 and transsulfuration to cystathionine, which requires pyridoxal-5′-phosphate.
5,10-Methylenetetrahydrofolate reductase (MTHFR) is a folic acid-related enzyme necessary for the remethylation of Hcy to methionine. It catalyzes the formation In this study, single nucleotide polymorphisms (SNPs) involved in homocysteine metabolism such as CT replacement in the 677th nucleotide in 5,10-methylenetetrahydrofolate reductase (MTHFR) enzyme; 68-bp insertion in the 844th nucleotide of cystathionine β-synthase (CBS) enzyme; 6-bp insertion/deletion in the region of 3′UTR in thymidylate synthase (TYMS) enzyme and 19-bp deletion in dihydrofolate reductase (DHFR) enzyme were investigated. The effects of these mutations on homocysteine levels were studied. As a result; we found that TT genotype of MTHFR 677 CT is an influencing factor on homocysteine levels in Turkish population. Furthermore, there seems to be another MTHFR 677 TT haplotype, which does not have an effect on homocysteine levels .Our data revealed that other SNPs did not have any influence on homocysteine levels.
Keywords: homocysteine; 5,10-methylenetetrahydrofolate reductase; cystathionine β-synthase; thymidylate synthase; dihydrofolate reductase MTHFR 677T gene are thought to be predisposed to develop elevated plasma tHcy. The effect of this mutation is modulated by serum folate status. 1, 7 Other polymorphisms were also reported to have a relation to Hcy levels 1, 3, 5, 6, 8, 9 and effects of these SNPs on Hcy levels were reported previously; however, the results were inconsistent.
So, we aimed to study these 4 SNPs at the Hcy metabolism related genes in healthy Turkish individuals to understand the effect of these mutations on Hcy levels.
Material and Methods
Our study included 296 healthy individuals (184 females, 112 males) admitted to Ankara University Medical School. Fasting plasma Hcy levels were measured using AxSYM homocysteine assay (Abbott, Wiesbaden, Germany). Genomic DNA was isolated from peripheral blood by conventional phenol-chloroform method. The patients had given written consent for the study.
Genetic analysis MTHFR 677 C-T polymorphism was determined by real-time polymerase chain reaction (PCR) method by melting curve analysis performed on Light Cycler (Roche Molecular Biochemicals, Mannheim, Germany) in barosilicate capillaries with MTHFR 677 CT polymorphism detection kit (Roche Molecular Biochemicals, Mannheim, Germany).
Genotyping of the DHFR 19-bp deletion was analyzed by PCR amplification using 3 allele-specific primers (5′-CCA CGG TCG GGG TAC CTG-3′; (forward-2) 5′-ACG GTC GGG GTG GCC GAC TC-3′; and (reverse) 5′-AAA AGG GGA ATC CAG TCG G-3′) as described previously. The 113-bp products were separated on 10% polyacrylamide gel. 4 PCR for CBS ex 8,68-bp insertion was carried out with the primers sense, 5′-CTGGCCTTGAGC-CCTGAA-3′ derived from intron 7; and antisense, 5′-GGCCGGGCTCTGGACT-3, derived from intron 8. Annealing temperature was 60°C. The PCR products were electrophoresed on a 2% agarose. Two fragments, 184 bp and 252 bp, were observed for insertion mutation as previously reported. 10 The TYMS gene 3′-translated region containing the insertion/deletion polymorphism was amplified by the PCR with forward 5′-CAAATCTGAGGGA GCTGAGT-3′ and reverse 5′-CAGATAAGTGGCAGTA CAGA-3′ primers, Annealing temperature was 58°C. The 148-bp PCR product was digested with Dra I (Fermentas, Vilnius, Lithuania). The digested products were separated on 10% nondenaturing polyacrylamide gels. 6 
Statistical Analysis
By taking natural logarithm of homocysteine level, distribution was normalized and parametric test (analysis of variance) was applied to these data. Nonparametric tests were used for the cases where original levels of homocysteine were used. Furthermore, multiple variant linear regression analysis that enables the control of the whole variables was used.
Results
Distribution of Hcy levels according to age and gender groups are given in Table 1 . Hcy levels were 12.64 ± 4.85 mmol/L in females and 15.17 ± 6.27 mmol/L in males. The difference was insignificant. It is obvious that Hcy levels increase by age as shown in Table 1 .
A concentration of 15 mmol/L is accepted as the borderline for normal levels. Concentration values greater than 15 mmol/L are accepted as high levels for homocysteine. We divided our group into 2 according to their Hcy levels. Possible risk allele distribution in our population is given in Table 2 . Tables 3 to 6 show the distribution of risk alleles of SNPs according to their Hcy levels. Only MTHFR 677 TT homozygosity showed statistically significance for high Hcy. Other SNPs did not show any effect on the Hcy levels. In Table 3 , we show the effect of MTHFR 677 TT on Hcy levels. Our data revealed that carrying TT in homozygote state has a significant effect on high Hcy levels. It is interesting that there are 11 individuals (5%.) carrying 677 TT; however, their Hcy levels were within normal range. Carrying 677 TT brings a 3-fold risk for high Hcy levels.
In this study, we also analyzed the interrelation between 4 SNPs. According to our data, frequency of carrying more than one risk allele at these SNPs did not reveal any importance. Only MTHFR 677 TT carriers had high homocysteine levels ( Table 6 ). Application of linear regression also gave the same result. In Tables 4 and 5 , we show our data on DHFR deletion and TYMS del polymorphism. Neither carrying deletion in heterozygous form nor in homozygous state of these polymorphism, revealed any effect on Hcy. Data on CBS 68-bp insertion on Hcy levels are given in Table 6 . No effect was observed. Data from analysis of individuals carrying the 2 risk alleles are presented in Table 7 . Only MTHFR 677 TT carriers have high Hcy levels.
Discussion
Four SNPs involved in Hcy metabolism such as 5,10-MTHFR gene 677CT; 68-bp insertion in the 844th nucleotide of CBS gene; 6-bp insertion/deletion in the region of 3′UTR in TYMS gene; and 19-bp deletion in DHFR gene were analyzed to understand their effects on Hcy levels in a group of healthy Turkish individuals. The effects of these mutations on Hcy levels were studied. Our results revealed that homozygote carriers for the MTHFR 677 TT mutation are most susceptible to elevated Hcy levels. However, we were not able to show the same result for the risk alleles of other 3 SNPs. Our data are in concordance with previous reports on MTHFR 677 TT, but our results on other SNPs and Hcy are in contrast to previous reports. 2, 3, 5, 6 This may be due to the nutritional differences between the groups that were studied.
Reports from our population mainly focused on MTHFR 677 C to T change and all found TT carriers to have elevated Hcy levels. [11] [12] [13] [14] Furthermore, our data revealed that there are 2 different populations at MTHFR 677 TT homozygotes. One group had high Hcy levels as expected, 9 whereas the other group had low Hcy levels. This may be due to high folate levels taken by diet, which we did not study in our population. On the other hand, another MTHFR 677 CC group had high homocysteine levels indicating that some other factors may cause this situation. This finding may be due to another Hcy-determining haplotype, which needs further study.
Our data revealed another very important clinical point of view: determination of homocysteine level is more important than DNA diagnosis of MTHFR 677 polymorphism. 
